| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |